GB0204756D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0204756D0
GB0204756D0 GBGB0204756.1A GB0204756A GB0204756D0 GB 0204756 D0 GB0204756 D0 GB 0204756D0 GB 0204756 A GB0204756 A GB 0204756A GB 0204756 D0 GB0204756 D0 GB 0204756D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0204756.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0204756.1A priority Critical patent/GB0204756D0/en
Publication of GB0204756D0 publication Critical patent/GB0204756D0/en
Priority to JP2003570843A priority patent/JP2005523291A/ja
Priority to US10/506,039 priority patent/US20050209198A1/en
Priority to EP03742878A priority patent/EP1480637A1/en
Priority to CNA038049007A priority patent/CN1638759A/zh
Priority to PCT/EP2003/002087 priority patent/WO2003072097A1/en
Priority to CA002477347A priority patent/CA2477347A1/en
Priority to AU2003210386A priority patent/AU2003210386A1/en
Priority to BR0308105-2A priority patent/BR0308105A/pt
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0204756.1A 2002-02-28 2002-02-28 Organic compounds Ceased GB0204756D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0204756.1A GB0204756D0 (en) 2002-02-28 2002-02-28 Organic compounds
JP2003570843A JP2005523291A (ja) 2002-02-28 2003-02-28 骨疾患の処置のためのビスホスホネートおよびｃｏｘ−２阻害剤を含む医薬組成物
US10/506,039 US20050209198A1 (en) 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
EP03742878A EP1480637A1 (en) 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
CNA038049007A CN1638759A (zh) 2002-02-28 2003-02-28 包含双膦酸类化合物和cox－2抑制剂、用于治疗骨病的药物组合物
PCT/EP2003/002087 WO2003072097A1 (en) 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
CA002477347A CA2477347A1 (en) 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
AU2003210386A AU2003210386A1 (en) 2002-02-28 2003-02-28 Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
BR0308105-2A BR0308105A (pt) 2002-02-28 2003-02-28 Composição farmacêutica compreendendo um bisfosfonato e um inibidor de cox-2 para o tratamento de doenças de ossos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0204756.1A GB0204756D0 (en) 2002-02-28 2002-02-28 Organic compounds

Publications (1)

Publication Number Publication Date
GB0204756D0 true GB0204756D0 (en) 2002-04-17

Family

ID=9932008

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0204756.1A Ceased GB0204756D0 (en) 2002-02-28 2002-02-28 Organic compounds

Country Status (9)

Country Link
US (1) US20050209198A1 (https=)
EP (1) EP1480637A1 (https=)
JP (1) JP2005523291A (https=)
CN (1) CN1638759A (https=)
AU (1) AU2003210386A1 (https=)
BR (1) BR0308105A (https=)
CA (1) CA2477347A1 (https=)
GB (1) GB0204756D0 (https=)
WO (1) WO2003072097A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040053900A1 (en) * 1998-12-23 2004-03-18 Pharmacia Corporation Method of using a COX-2 inhibitor and an aromatase inhibitor as a combination therapy
CN107540726A (zh) * 2017-08-22 2018-01-05 河北科技大学 一类肽基塞来昔布衍生物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2294879A (en) * 1994-10-19 1996-05-15 Merck & Co Inc Cylcooxygenase-2 Inhibitors
AU1525700A (en) * 1998-11-19 2000-06-05 Board Of Trustees Of The University Of Arkansas, The Increasing bone strength with selected bisphosphonates
BR9916536A (pt) * 1998-12-23 2002-01-02 Searle & Co Método para o tratamento ou prevenção de um distúrbio de neoplasia em um mamìfero em necessidade deste tratamento ou prevenção, e, combinação
ES2394211T3 (es) * 2000-06-20 2013-01-23 Novartis Ag Procedimiento de administración de bifosfonatos
BR0213410A (pt) * 2001-10-19 2004-11-03 Novartis Ag Usos farmacêuticos de bisfosfonatos

Also Published As

Publication number Publication date
AU2003210386A1 (en) 2003-09-09
BR0308105A (pt) 2005-01-04
US20050209198A1 (en) 2005-09-22
JP2005523291A (ja) 2005-08-04
EP1480637A1 (en) 2004-12-01
WO2003072097A1 (en) 2003-09-04
CA2477347A1 (en) 2003-09-04
CN1638759A (zh) 2005-07-13

Similar Documents

Publication Publication Date Title
GB0203276D0 (en) Organic compounds
GB0202873D0 (en) Organic compounds
GB0209265D0 (en) Organic compounds
GB0205281D0 (en) Organic compounds
GB0200429D0 (en) Organic compounds
EG23462A (en) Organic compounds
GB0209481D0 (en) Organic compounds
GB0202874D0 (en) Organic compounds
GB0203061D0 (en) Organic compounds
GB0204756D0 (en) Organic compounds
GB0211261D0 (en) Organic compounds
GB0210535D0 (en) Organic compounds
GB0206216D0 (en) Organic compounds
GB0207500D0 (en) Organic compounds
GB0203189D0 (en) Organic compounds
GB0204752D0 (en) Organic compounds
GB0202381D0 (en) Organic compounds
GB0204763D0 (en) Organic compounds
GB0204765D0 (en) Organic compounds
GB0204766D0 (en) Organic compounds
GB0201913D0 (en) Organic compounds
GB0205280D0 (en) Organic compounds
GB0201610D0 (en) Organic compounds
GB0205537D0 (en) Organic compounds
GB0201609D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)